CHEN Jialiang, XU Jiaruo, ZHOU Yuehua, et al. Aristolochic acid-induced liver injury in rats and its effects on autophagy factors. [J]. Academic Journal of Shanghai University of Traditional Chinese Medicine 35(5):44-51(2021)
DOI:
CHEN Jialiang, XU Jiaruo, ZHOU Yuehua, et al. Aristolochic acid-induced liver injury in rats and its effects on autophagy factors. [J]. Academic Journal of Shanghai University of Traditional Chinese Medicine 35(5):44-51(2021) DOI: 10.16306/j.1008-861x.2021.05.008.
Aristolochic acid-induced liver injury in rats and its effects on autophagy factors
Objective:,2,To observe the aristolochic acid Ⅰ(AA Ⅰ) -induced liver injury in rats and investigate its influence on autophagy-related factors.,Methods:,2,Male Wistar rats were randomly divided into the normal group, autophagy inhibitor group, AA Ⅰ low-dose(20 mg/kg) group, AA Ⅰ high-dose(40 mg/kg) group, autophagy inhibitor + AA Ⅰ low-dose group and autophagy inhibitor + AA Ⅰ high-dose group, five rats in each group.Rats in the autophagy inhibitor treatment groups were intraperitoneally injected with 3-methyladenine(3-MA, 20 mg/kg) in advance.One hour after the inhibitor intervention, the AA Ⅰ treatment groups were intraperitoneally injected with AA Ⅰ at the corresponding dose.Drug intervention lasted for 9 days.After the last administration, blood was taken and liver was isolated.The serum levels of alanine aminotransferase(ALT) and aspartate aminotransferase(AST) were detected by biochemical analyzer, and the ratio was calculated.The morphological changes of liver tissue were observed under light and transmission electron microscope.The mRNA expression levels of ,Beclin 1,LC3, and ,p53, were detected by PCR.The protein expression levels of Beclin 1, LC3 and p53 were detected by immunohistochemistry.,Results:,2,①Compared with the normal group, the serum AST level in the AA Ⅰ low-dose group was increased significantly(,P,<,0.05), and the AST/ALT ratio was obviously increased in the AA Ⅰ low-dose and high-dose groups(,P,<,0.05,P,<,0.01) .Compared with the autophagy inhibitor group, the AST/ALT ratio was increased significantly in the autophagy inhibitor + AAⅠ high-dose group and autophagy inhibitor + AA Ⅰ low-dose group(,P,<,0.01) .② After HE staining, hepatocyte swelling was observed in the AA Ⅰ low-dose and high-dose groups, and the degree of injury was more significant in the AA Ⅰ high-dose group. Hepatocyte hemorrhagic necrosis was found in the autophagy inhibitor + AA Ⅰ high-dose group, and the degree of injury was significantly worse than that in the AA Ⅰ high-dose group. Transmission electron microscopy showed the mitochondria swelling in the AA Ⅰ low-dose and high-dose groups, and the steatosis was also observed in the AA Ⅰ high-dose group.Mitochondrion swelling was found in the autophagy inhibitor + AA Ⅰ low-dose group, as well as the endoplasmic reticulum swelling and implicit autophagy bodies in the autophagy inhibitor + AA Ⅰ high-dose group.③Compared with the normal group, the expression of ,p53, mRNA was significantly up-regulated in the AA Ⅰ low-dose and high-dose groups(,P,<,0.05) .Compared with the autophagy inhibitor group, the expression of ,LC3, mRNA was significantly decreased in the autophagy inhibitor + AA Ⅰ low-dose group(,P,<,0.05), and the expressions of ,Beclin 1, and ,LC3, mRNA were significantly decreased in the autophagy inhibitor + AA Ⅰ high-dose group(,P,<,0.01) .The mRNA expressions of ,Beclin 1,LC3, and ,p53, in the autophagy inhibitor + AA Ⅰ high-dose group were significantly lower than those in the autophagy inhibitor + AA Ⅰ low-dose group(,P,<,0.05,P,<,0.01) .④Compared with the normal group, the protein expressions of Beclin 1, LC3 and p53 were significantly up-regulated in the AA Ⅰ low-dose and high-dose groups(,P,<,0.01), and the expressions of these three proteins in the AA Ⅰ high-dose group were significantly higher than those in the AA Ⅰ low-dose group(,P,<,0.05,P,<,0.01) .Compared with the autophagy inhibitor group, after the co-treatment of autophagy inhibitor and AA Ⅰ with different doses, the expressions of these three proteins were significantly up-regulated(,P,<,0.01) .Compared with the autophagy inhibitor + AA Ⅰ low-dose group, the expressions of Beclin 1 and LC3 proteins were decreased significantly(,P,<,0.05,P,<,0.01) and the expression of p53 protein was increased significantly(,P,<,0.01) in the autophagy inhibitor + AA Ⅰ high-dose group.,Conclusion:,2,AA Ⅰ can induce liver injury in rats, and autophagy factors promote AA Ⅰ liver injury.Its mechanism may be related to regulating p53 protein expression and inducing autophagy.
ALVIN W T,SONG L P,HUANG M N,et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia[J]. Sci Transl Med,2017,9(412): 6446-6457.
LV D G,LUO X L,CHEN Z,et al. Apelin/APJ signaling activates autophagy to promote human lung adenocarcinoma cell migration[J]. Life Sci,2021,281(15): 119763.
LUO Y D,FANG L,YU H Q,et al. p53 haploinsufficiency and increased mTOR signaling define a subset of aggressive hepatocellular carcinoma[J]. J Hepatol,2021,74(1): 96-108.
FENG F F,CHENG P,SUN C,et al. Inhibitory effects of polyphyllins Ⅰ and Ⅶ on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition[J]. Chin J Nat Med,2019,17(10): 768-777.
SANTOS L,MOLINA E G,LEON R,et al. AST/ALT ratio is the most important independent predictor of severe hepatic fibrosis in hispanic and caucasian patients with nonalcoholic steatohepatitis[J]. Gastroenterology,2001,120(5): 2764-2768.
IMPERIALE T F,SAID A T,CUMMINGS O W,et al. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C[J]. Am J Gastroenterol,2000,95(9): 2328-2332.
CARMONA-GUTIERREZ D,ZIMMERMANN A,KAINZ K,et al. The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species[J]. Nat Commun,2019,10(1): 1662-1664.
WAN J H,CHEN J,WU D Y,et al.Regulation of autophagy affects the prognosis of mice with severe acute pancreatitis[J]. Dig Dis Sci,2018,63(10): 2639-2650.
XIA H J,DOUGLAS R G,ZOU W P,et al. Autophagy in tumour immunity and therapy [J]. Nat Rev Cancer,2021,21(5): 281-297.